Cancer program awarded $2 million+ per year by National Cancer Institute
The Prisma Health Cancer Institute has been allocated increased funding from the National Cancer Institute (NCI), bringing the grant contribution to more than $2 million per year.
“This is an important achievement as we expand the program to the Midlands,” said Larry Gluck, MD, Medical Director of the institute and Chair of Prisma Health Oncology Services. “Our team has substantially increased clinical trial accruals, despite the challenges of COVID. This underscores the dedication of our team to provide high-quality cancer clinical trials.”
The grant is awarded by the NCI as part of the National Community Oncology Research Program (NCORP).
The Cancer Institute program dates to 1988 and has been continuously funded by the NCI since 1995. The increase will allow Prisma Health to strengthen and expand clinical trial options.
Prisma Health’s Cancer Institute is an Academic Comprehensive Cancer Program and provides clinical services including cancer surgery and gynecologic, pediatric, medical and radiation oncology. Offerings include an accredited bone marrow transplant program, a comprehensive breast health program, integrated oncology and survivorship programs, multidisciplinary centers, and nurse navigators, as well as the Institute for Translational Oncology Research (ITOR) and a dedicated Phase 1 Clinical Research Unit (CRU).